Sign in
Taking people in United KingdomNo phase

Tests a heart MRI scan without contrast for scarring in dialysis patients

Checks a heart MRI scan for scarring in adults with kidney failure on dialysis.

Key facts

Who runs it
University of Leicester
Where
Leicester, United KingdomSee the site
Trial code
Registry title
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Status
Recruiting
People taking part
9 people, planned
Started
3 Nov 2019
Planned end
31 Dec 2025
Type of study
Observational
Treatments tested
  • Cardiac MRI scan
  • Echocardiogram
  • Cardiac explantation
  • 48-Hour continuous cardiac monitoring
  • Blood samples
Record updated
18 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults on haemodialysis for more than 3 months who are on a supportive care register and are expected to die within 12 months. It tests a heart MRI scar measure.

Age
18 years or older
Sex
All sexes can join
Disease stage
On haemodialysis for more than 3 months, on the supportive care register, with death expected within the next 12 months
Earlier treatment
Must have been on haemodialysis for more than 3 months

Main reasons for not taking part

  • Cannot have an MRI scan (for example pacemaker, incompatible metal implants, claustrophobia)
  • Expected or possible infiltrative heart muscle disease (for example amyloidosis)
  • Cannot give informed consent
  • Cannot understand written and spoken English
  • Does not consent to donating the heart for research after death

This trial only enrols participants on dialysis. The registry sentence this rests on: Prevalent haemodialysis patient (more than 3 months)

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Prevalent haemodialysis patient (more than 3 months)
  • Active on the supportive care register with anticipated death in the subsequent 12 months
  • Able to give informed consent
  • Consent to donation of heart for research following death
  • Able to understand written and verbal explanations in English

Who cannot take part

  • Contraindication to MRI scan (e.g. pacemaker, incompatible metallic implants, claustrophobia)
  • Patients with expected or potential infiltrative cardiomyopathy (e.g. amyloidosis)
  • Unable to give informed consent
  • Unable to understand written and verbal explanations in English

Where in United Kingdom

  • University Hospitals of Leicester NHS TrustLeicester, United KingdomContact: James Burton, FRCPTaking people

About the trial

What the trial wants to find out

There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1 mapping, may provide a solution to this. To assess the accuracy of this novel technique in dialysis patients, it is essential to undertake a study which compares native T1 mapping to actual levels of scarring in the hearts of patients on dialysis.

The group in the trial

  • Haemodialysis patients

    The plans for patient recruitment were developed in partnership with our local haemodialysis patient participation and involvement group. Patients will be identified from the supportive care register established for haemodialysis patients in Leicester in 2008. Inclusion: * Prevalent haemodialysis patient (more than 3 months) * Active on the supportive care register with anticipated death in the subsequent 12 months * Able to give informed consent * Consent to donation of heart for research following death * Able to understand written and verbal explanations in English Exclusion: * Contraindication to MRI scan (e.g. pacemaker, incompatible metallic implants, claustrophobia) * Patients with expected or potential infiltrative cardiomyopathy (e.g. amyloidosis) * Unable to give informed consent * Unable to understand written and verbal explanations in English

    Treatment: Cardiac MRI scan, Echocardiogram, Cardiac explantation, 48-Hour continuous cardiac monitoring, and Blood samples

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Validating the Accuracy of Novel, Non-contrast, Cardiac Magnetic resOnaNce Imaging in Defining Myocardial FIbRosis in Patients With End-stage Renal Disease on haeModialysis: the CONFIRM Study
Plain-language title
Tests a heart MRI scan without contrast for scarring in dialysis patientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
18 April 2025